Clinical Trial

PARTial BREast RECONstruction With Chest Wall Perforator Flap

Study acronym: PartBreCon
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 11, 2024 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to ascertain the outcomes following partial breast reconstruction using chest wall perforator flaps after breast conservation surgery.
Trial Details
NCT Number NCT06728527
Lead Sponsor Cambridge University Hospitals NHS Foundation Trust
Collaborators: Oxford University Hospitals NHS Trust
Conditions Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Carcinoma, Breast Neoplasms, Breast Surgery, Breast Reconstruction Surgery
Enrollment 1,001 participants
Start Date 2023-06-01
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-11